title: Effect of hepatitis B and C clearance on atazanavir exposure.
authors: 3rd Division of Infectious Diseases, L. Sacco University Hospital, Via GB Grassi 74, 20157, Milan, Italy. cristina.gervasoni@unimi.it.
authors: Cristina
authors: C
authors: Gervasoni
authors: Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
authors: Dario
authors: D
authors: Cattaneo
authors: Clinical Microbiology Virology and Diagnosis of Bioemergency, L Sacco University Hospital, Milan, Italy.
authors: Valeria
authors: V
authors: Micheli
authors: Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
authors: Valentina
authors: V
authors: Di Cristo
authors: 3rd Division of Infectious Diseases, L. Sacco University Hospital, Via GB Grassi 74, 20157, Milan, Italy.
authors: Laura
authors: L
authors: Milazzo
mesh_terms: D000998:Antiviral Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000069446:Atazanavir Sulfate / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy / Q000378:metabolism*; D006509:Hepatitis B / Q000188:drug therapy / Q000378:metabolism*; D006526:Hepatitis C / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D000069446:Atazanavir Sulfate; C486464:telaprevir